PL2474529T3 - Formy krystaliczne farmaceutycznej substancji czynnej - Google Patents

Formy krystaliczne farmaceutycznej substancji czynnej

Info

Publication number
PL2474529T3
PL2474529T3 PL10196836T PL10196836T PL2474529T3 PL 2474529 T3 PL2474529 T3 PL 2474529T3 PL 10196836 T PL10196836 T PL 10196836T PL 10196836 T PL10196836 T PL 10196836T PL 2474529 T3 PL2474529 T3 PL 2474529T3
Authority
PL
Poland
Prior art keywords
active pharmaceutical
crystalline forms
pharmaceutical ingredient
ingredient
crystalline
Prior art date
Application number
PL10196836T
Other languages
English (en)
Inventor
Arthur Pichler
Andreas Hotter
Clemens Häfele
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of PL2474529T3 publication Critical patent/PL2474529T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
PL10196836T 2010-12-23 2010-12-23 Formy krystaliczne farmaceutycznej substancji czynnej PL2474529T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10196836.0A EP2474529B1 (en) 2010-12-23 2010-12-23 Crystalline forms of an active pharmaceutical ingredient

Publications (1)

Publication Number Publication Date
PL2474529T3 true PL2474529T3 (pl) 2014-10-31

Family

ID=43734023

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10196836T PL2474529T3 (pl) 2010-12-23 2010-12-23 Formy krystaliczne farmaceutycznej substancji czynnej

Country Status (5)

Country Link
EP (1) EP2474529B1 (pl)
JP (1) JP5847567B2 (pl)
ES (1) ES2492673T3 (pl)
PL (1) PL2474529T3 (pl)
SI (1) SI2474529T1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140243383A1 (en) * 2011-08-24 2014-08-28 Cadila Healthcare Limited Pharmaceutical compositions of silodosin
JP2016147811A (ja) * 2015-02-10 2016-08-18 ダイト株式会社 シロドシンγ型結晶の製造方法
CN109824569B (zh) * 2019-04-04 2022-09-20 重庆医药高等专科学校 一种西罗多辛晶型i及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9225348D0 (en) 1992-12-03 1993-01-27 Pilkington Plc Bridged photochromics
UA78854C2 (en) * 2002-09-06 2007-04-25 Kissei Pharmaceutical Crystal for an oral solid drug and oral solid drug for dysuria treatment containing the same
EA008196B1 (ru) 2002-12-16 2007-04-27 Киссеи Фармасьютикал Ко., Лтд. Твердая лекарственная форма для перорального применения

Also Published As

Publication number Publication date
JP2012131786A (ja) 2012-07-12
EP2474529A1 (en) 2012-07-11
EP2474529B1 (en) 2014-05-14
JP5847567B2 (ja) 2016-01-27
ES2492673T3 (es) 2014-09-10
SI2474529T1 (sl) 2014-12-31

Similar Documents

Publication Publication Date Title
ZA201306237B (en) Solid forms of a pharmaceutically active substance
HK1185879A1 (zh) 作為 抑制劑的藥物活性化合物
IL238713A0 (en) Self-regulating active pharmaceutical ingredient release
ZA201405139B (en) Active ingredient combinations having insecticidal and acaricidal properties
PL2642993T3 (pl) Kompozycje rotygotyny lub farmaceutycznie dopuszczalnych soli rotygotyny
GB2486567B (en) Pharmaceutical formulation
EP2734513A4 (en) INTERMEDIATE PRODUCT OF STATIN MEDICINES AND THEIR MANUFACTURE
HK1179534A1 (en) Coated preparation containing azosemide as active ingredient
HUP1000565A2 (en) Process for the preparation of pharmaceutically active compound and intermediers
PL2474529T3 (pl) Formy krystaliczne farmaceutycznej substancji czynnej
PL2585445T3 (pl) Polimorfy aktywnego składnika farmaceutycznego
SI2938328T1 (sl) Monolitna farmacevtska oblika za prirejeno sproščanje kombinacije učinkovin
HUP1000444A2 (en) Process for the preparation of a pharmaceutical active ingredient
LT2391352T (lt) Farmacinės veikliųjų medžiagų atpalaidavimo formos
GB201001203D0 (en) Use of pharmaceutically active compounds
EP2536688A4 (en) STABLE DOSAGE FORMS OF LEVOMILNACIPRAN
PL2407159T3 (pl) Kompozycje farmaceutyczne olmesartanu
ZA201303371B (en) Crystalline pharmaceutically active ingredients
HUP1000429A2 (en) Basic salts of a pharmaceutical active ingredient
EP2738174A4 (en) NOVEL PYRIMIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME AS ACTIVE INGREDIENT
HK1186655A1 (zh) 含有 或其衍生物用作活性成分的抗瘧疾藥物
HUP1000431A2 (en) Acid addition salts of a pharmaceutical active ingredient
IL224929A (en) Axl inhibitors and preparations containing them
RS20100352A3 (en) METHOD OF PREPARATION AND USE OF PHARMACOLOGICAL ACTIVE N-CARBAMYLMETHYL-4 (R) -Phenyl-2-Pyrrolidinone
GB201012047D0 (en) Pharmaceutical formulations